Talk Bio

Actionable Insights Powered by AI

Subscribe

ENT1

iTeos to Shut Down Operations After TIGIT Therapy Setback

talkbio0Tagged , , , , , , , , , , , , , ,

iTeos Therapeutics; TIGIT failure; GSK exit; clinical trial failure; belrestotug; asset sale; immuno-oncology; EOS-984; EOS-215; ENT1 obesity program

Read More